Effectiveness of One Dose of Oral Cholera Vaccine in Response to an Outbreak: A Case-Cohort Study

Hdl Handle:
http://hdl.handle.net/10144/618692
Title:
Effectiveness of One Dose of Oral Cholera Vaccine in Response to an Outbreak: A Case-Cohort Study
Authors:
Azman, AS; Parker, LA; Rumunu, J; Tadesse, F; Grandesso, F; Deng, LL; Lino, RL; Bior, BK; Lasuba, M; Page, AL; Ontweka, L; Llosa, AE; Cohuet, S; Pezzoli, L; Sodjinou, DV; Abubakar, A; Debes, AK; Mpairwe, AM; Wamala, JF; Jamet, C; Lessler, J; Sack, DA; Quilici, ML; Ciglenecki, I; Luquero, FJ
Journal:
The Lancet. Global health
Abstract:
Oral cholera vaccines represent a new effective tool to fight cholera and are licensed as two-dose regimens with 2-4 weeks between doses. Evidence from previous studies suggests that a single dose of oral cholera vaccine might provide substantial direct protection against cholera. During a cholera outbreak in May, 2015, in Juba, South Sudan, the Ministry of Health, Médecins Sans Frontières, and partners engaged in the first field deployment of a single dose of oral cholera vaccine to enhance the outbreak response. We did a vaccine effectiveness study in conjunction with this large public health intervention.
Publisher:
Elsevier
Issue Date:
1-Nov-2016
URI:
http://hdl.handle.net/10144/618692
DOI:
10.1016/S2214-109X(16)30211-X
PubMed ID:
27765293
Language:
en
ISSN:
2214-109X
Appears in Collections:
Other Diseases

Full metadata record

DC FieldValue Language
dc.contributor.authorAzman, ASen
dc.contributor.authorParker, LAen
dc.contributor.authorRumunu, Jen
dc.contributor.authorTadesse, Fen
dc.contributor.authorGrandesso, Fen
dc.contributor.authorDeng, LLen
dc.contributor.authorLino, RLen
dc.contributor.authorBior, BKen
dc.contributor.authorLasuba, Men
dc.contributor.authorPage, ALen
dc.contributor.authorOntweka, Len
dc.contributor.authorLlosa, AEen
dc.contributor.authorCohuet, Sen
dc.contributor.authorPezzoli, Len
dc.contributor.authorSodjinou, DVen
dc.contributor.authorAbubakar, Aen
dc.contributor.authorDebes, AKen
dc.contributor.authorMpairwe, AMen
dc.contributor.authorWamala, JFen
dc.contributor.authorJamet, Cen
dc.contributor.authorLessler, Jen
dc.contributor.authorSack, DAen
dc.contributor.authorQuilici, MLen
dc.contributor.authorCiglenecki, Ien
dc.contributor.authorLuquero, FJen
dc.date.accessioned2016-11-06T13:25:43Z-
dc.date.available2016-11-06T13:25:43Z-
dc.date.issued2016-11-01-
dc.identifier.citationEffectiveness of One Dose of Oral Cholera Vaccine in Response to an Outbreak: A Case-Cohort Study. 2016, 4 (11):e856-e863 Lancet Glob Healthen
dc.identifier.issn2214-109X-
dc.identifier.pmid27765293-
dc.identifier.doi10.1016/S2214-109X(16)30211-X-
dc.identifier.urihttp://hdl.handle.net/10144/618692-
dc.description.abstractOral cholera vaccines represent a new effective tool to fight cholera and are licensed as two-dose regimens with 2-4 weeks between doses. Evidence from previous studies suggests that a single dose of oral cholera vaccine might provide substantial direct protection against cholera. During a cholera outbreak in May, 2015, in Juba, South Sudan, the Ministry of Health, Médecins Sans Frontières, and partners engaged in the first field deployment of a single dose of oral cholera vaccine to enhance the outbreak response. We did a vaccine effectiveness study in conjunction with this large public health intervention.en
dc.languageENG-
dc.language.isoenen
dc.publisherElsevieren
dc.rightsArchived with thanks to The Lancet. Global healthen
dc.titleEffectiveness of One Dose of Oral Cholera Vaccine in Response to an Outbreak: A Case-Cohort Studyen
dc.identifier.journalThe Lancet. Global healthen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.